PHBI (Pharmagreen Biotech) Days Payable: 0.00 (As of Jun. 2023)

What is Pharmagreen Biotech Days Payable?

Pharmagreen Biotech PHBI Days Payable is 0.00 as of Jun. 2023.

Pharmagreen Biotech's average Accounts Payable for the three months ended in Jun. 2023 was $0.69 Mil. Pharmagreen Biotech's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.00 Mil.

The historical rank and industry rank for Pharmagreen Biotech's Days Payable or its related term are showing as below:

PHBI's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 90.69
* Ranked among companies with meaningful Days Payable only.

Pharmagreen Biotech's Days Payable stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00). stayed the same

Pharmagreen Biotech Days Payable Related Terms

Pharmagreen Biotech Days Payable Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Days Payable Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Days Payable

Get a 7-Day Free Trial

0.00

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	62,780.00	0.00

PHBI vs DVLP, CSTF, BLMS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Days Payable falls into.

Save Embed

Pharmagreen Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Pharmagreen Biotech's Days Payable for the fiscal year that ended in Sep. 2022 is calculated as

	Days Payable (A: Sep. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2021 )	+	Accounts Payable (A: Sep. 2022 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2022 )	*	Days in Period
=	( (0.58	+	0.645)	/	2 )	/	0	*	365
=	0.6125					/	0	*	365
=	N/A

Pharmagreen Biotech's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.691	+	0.697)	/	2 )	/	0	*	365 / 4
=	0.694					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Pharmagreen Biotech (PHBI) has a Days Payable of 0.00 as of Jun. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmagreen Biotech and its competitors.

Is Pharmagreen Biotech's Days Payable too high?

Pharmagreen Biotech's current Days Payable is 0.00.

How does Pharmagreen Biotech's Days Payable compare to DVLP and CSTF?

Pharmagreen Biotech's Days Payable of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Drug Manufacturers company?

The median Days Payable among Drug Manufacturers companies is 90.69, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmagreen Biotech and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagreen Biotech's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pharmagreen Biotech stock overvalued right now?

Pharmagreen Biotech (PHBI) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Days Payable is 0.00 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies DVLP CSTF BLMS CANB BBBT SKYI EGSE GCAN UBQU SGBI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Address 112 North Curry Street, Carson, NV, USA, 89703

Website https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.